Stock IPCALAB IPCA LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Ipca Laboratories Limited Bombay S.E.

Equities

IPCALAB

INE571A01038

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:50 2024-04-26 am EDT 		5-day change 1st Jan Change
1,339 INR +0.82% Intraday chart for Ipca Laboratories Limited +0.14% +20.23%
Mar. 29 Ipca Laboratories Limited Announces Cessation of Anand T. Kusre as an Independent Director CI
Mar. 29 Ipca Laboratories Limited Appoints Swati Arvind Patankar as an Independent Director CI

Business Summary

Ipca Laboratories Limited is an India-based pharmaceutical company. The Company is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The products of the Company are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing API’s and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd and Tonira Exports Limited.

Number of employees: 16,167

Sales per Business

INR in Million2022Weight2023Weight Delta
Branded Generics
53.8 %
30,028 51.5 % 33,597 53.8 % +11.88%
Active Pharmaceutical Ingredients
24.4 %
15,132 26.0 % 15,217 24.4 % +0.56%
Generics
21.2 %
12,504 21.4 % 13,255 21.2 % +6.00%
Miscellaneous
0.5 %
300 0.5 % 298 0.5 % -0.57%
Export Incentives
0.1 %
302 0.5 % 59 0.1 % -80.34%
Sundry Balances Written Back
0.0 %
32 0.1 % 17 0.0 % -46.06%

Sales per region

INR in Million2022Weight2023Weight Delta
India
52.3 %
30,112 51.7 % 32,655 52.3 % +8.44%
Americas
10.2 %
6,707 11.5 % 6,367 10.2 % -5.07%
Europe
9.3 %
5,439 9.3 % 5,783 9.3 % +6.32%
Asia (excluding India)
7.8 %
4,615 7.9 % 4,885 7.8 % +5.84%
Africa
7.6 %
4,754 8.2 % 4,769 7.6 % +0.31%
United Kingdom
4.8 %
2,597 4.5 % 2,998 4.8 % +15.44%
Australasia
4.4 %
2,476 4.2 % 2,777 4.4 % +12.17%
Commonwealth of Independent States
3.5 %
1,598 2.7 % 2,210 3.5 % +38.29%

Managers

Managers TitleAgeSince
Ajitkumar Bhanwarlal Jain CEO
 Chief Executive Officer 68 80-04-01
Pranay Godha CEO
 Chief Executive Officer 51 03-04-15
Premchand Gigalal Godha CHM
 Chairman 77 75-10-30
Hitesh Kumar Maheshwari CTO
 Chief Tech/Sci/R&D Officer 50 23-10-15
Pabitra Kumar Bhattacharya CIO
 Chief Investment Officer - -
Ashok Kumar CTO
 Chief Tech/Sci/R&D Officer 70 00-09-05
Anil Pareek CTO
 Chief Tech/Sci/R&D Officer 67 00-09-10
Harish Pandurang Kamath CMP
 Compliance Officer 64 93-09-19
Sanjay Kapadia PRN
 Corporate Officer/Principal - -
Pabitrakumar Kalipada Bhattacharyya PRN
 Corporate Officer/Principal 55 -

Members of the board

Members of the board TitleAgeSince
Premchand Gigalal Godha CHM
 Chairman 77 75-10-30
Prashant Premchand Godha BRD
 Director/Board Member 76 11-08-15
Pranay Godha CEO
 Chief Executive Officer 51 03-04-15
Ajitkumar Bhanwarlal Jain CEO
 Chief Executive Officer 68 80-04-01
Manisha Premnath BRD
 Director/Board Member 50 14-09-20
Narendra Mairpady BRD
 Director/Board Member 69 22-10-19
Kamal Kishore Seth BRD
 Director/Board Member 78 19-03-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 253,700,000 132,806,211 ( 52.35 %) 0 52.35 %

Shareholders

NameEquities%Valuation
Kaygee Investments Pvt Ltd.
21.47 %
54,478,390 21.47 % 809 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt)
7.758 %
19,683,417 7.758 % 292 M ₹
DSP Asset Managers Pvt. Ltd.
7.171 %
18,194,178 7.171 % 270 M ₹
Kaygee Laboratories Pvt Ltd.
6.610 %
16,770,000 6.610 % 249 M ₹
Chandurkar Investments Pvt Ltd.
5.501 %
13,956,010 5.501 % 207 M ₹
Paschim Chemicals Pvt Ltd.
3.996 %
10,138,000 3.996 % 151 M ₹
Kotak Mahindra Asset Management Co. Ltd.
3.698 %
9,382,300 3.698 % 139 M ₹
Usha M Chandurkar
3.272 %
8,302,000 3.272 % 123 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
2.902 %
7,362,928 2.902 % 109 M ₹
Premchand Gigalal Godha
2.292 %
5,814,680 2.292 % 86 M ₹

Holdings

NameEquities%Valuation
UNICHEM LABORATORIES LIMITED
52.67%
 37,081,011 52.67% 217,188,673 $
LYKA LABS LIMITED
36.34%
 12,024,923 36.34% 15,275,861 $

Company contact information

Ipca Laboratories Ltd.

125, Kandivli Industrial Estate Kandivili West

400067, Mumbai

+91 22 6647 4444

http://www.ipca.com
address Ipca Laboratories Limited(IPCALAB)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Ipca Laboratories Limited

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
1,338 INR
Average target price
1,163 INR
Spread / Average Target
-13.10%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. IPCALAB Stock
  4. IPCALAB Stock
  5. Company Ipca Laboratories Limited